[Form 4] Lincoln National Corp. Insider Trading Activity
Rhea-AI Filing Summary
Sean Woodroffe, Executive Vice President and Chief People, Culture & Communications Officer of Lincoln National Corporation (LNC), reported transactions dated 08/15/2025. On that date he exercised an employee stock option with a $21.13 exercise price to acquire 16,164 shares and simultaneously sold 16,164 shares at a weighted average price of $40.90. The filing notes 1,880.83 shares were acquired via dividend reinvestment since his last report. The Form 4 shows beneficial ownership figures of 172,146.48 shares following the acquisition line (including reinvested dividends) and 155,982.48 shares following the sale line. The underlying option vests in three equal installments on May 24, 2024, 2025 and 2026 and expires May 24, 2033.
Positive
- Substantial remaining beneficial ownership: Filing shows 155,982.48 shares after the reported sale, indicating continued significant ownership.
- Dividend reinvestment added shares: 1,880.83 shares were acquired through dividend reinvestment since the last report, increasing long-term stake.
Negative
- Insider sale recorded: The reporting person sold 16,164 shares on 08/15/2025 at a weighted average price of $40.90.
Insights
TL;DR: Routine option exercise and contemporaneous sale; reporting shows substantial remaining beneficial ownership and dividend reinvestment.
The reported transactions are typical for executive equity compensation: exercise of a vested option at $21.13 for 16,164 shares paired with an immediate sale of the same number of shares at a weighted average of $40.90. The filing documents that dividend reinvestment added 1,880.83 shares since the prior report and reports beneficial ownership balances of 172,146.48 and 155,982.48 shares after the acquisition and sale lines, respectively. This Form 4 is a required disclosure of changes in beneficial ownership and contains detailed footnotes on price ranges and vesting schedule; no additional corporate governance actions are disclosed in this filing.
TL;DR: Option exercise followed by sale appears administratively normal; vesting schedule and option expiration are disclosed.
The filing identifies an employee stock option with a $21.13 exercise price that vested in three equal installments on May 24, 2024, 2025 and 2026 and expires May 24, 2033. The reporting person exercised 16,164 option shares (Table II) and sold 16,164 common shares (Table I) on 08/15/2025; the sale price reported is a weighted average of $40.89 to $40.93. The report also quantifies dividend reinvestment of 1,880.83 shares since the last filing. These details align with standard equity compensation activity and the filing includes the required explanatory footnotes and attorney-in-fact signature.